From resveratrol to ISIDE11: how to activate SIRT1 and improve endothelial function? New therapeutic insights for methylenetetrahydrofolate reductase deficiency

Cell Mol Life Sci. 2022 Jul 27;79(8):451. doi: 10.1007/s00018-022-04484-y.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Homocystinuria*
  • Humans
  • Methylenetetrahydrofolate Reductase (NADPH2) / deficiency
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Muscle Spasticity
  • Psychotic Disorders
  • Resveratrol / pharmacology
  • Resveratrol / therapeutic use
  • Sirtuin 1
  • Thrombosis*

Substances

  • MTHFR protein, human
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • SIRT1 protein, human
  • Sirtuin 1
  • Resveratrol

Supplementary concepts

  • Methylenetetrahydrofolate reductase deficiency